Steroid-free immunosuppression during and after liver transplantation - A 3-yr follow-up report

Clinical Transplantation

Volumn 17, Issue 3, 2003, Pages 177-182

  Pirenne, Jacques ^a   Aerts, Raymond ^a   Koshiba, Takaaki ^a   Van Gelder, Frank ^a   Roskams, Tania ^a   Schetz, Marie ^a   Verhaegen, Marleen ^a   Lauwers, Peter ^a   Fevery, Johan ^a   Nevens, Frederick ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Liver transplantation; Steroid free

Indexed keywords

AMPHOTERICIN; AMPICILLIN; AZATHIOPRINE; CALCINEURIN INHIBITOR; CEFOTAXIME; COTRIMOXAZOLE; CYCLOSPORIN A; CYTOMEGALOVIRUS ANTIBODY; GANCICLOVIR; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BACTERIAL INFECTION; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CUSHING DISEASE; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DIARRHEA; DOSE TIME EFFECT RELATION; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FOLLOW UP; GRAFT SURVIVAL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTION SENSITIVITY; INTRAOPERATIVE PERIOD; LIVER TRANSPLANTATION; NEUROTOXICITY; OSTEOPOROSIS; PILOT STUDY; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; SURVIVAL RATE;

AZATHIOPRINE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; METHYLPREDNISOLONE HEMISUCCINATE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; TACROLIMUS; TIME FACTORS;

EID: 0038339509     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2003.00017.x     Document Type: Article

References (24)

1. Trouillot TE, Shrestha R, Kam I, Wachs M, Everson GT. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis. Liver Transpl Surg 1999: 5: 375.
2. Everson GT, Trouillot T, Wachs M et al. Early steroid withdrawal in liver transplantation is safe and beneficial. Liver Transpl Surg 1999: 5: S48.
3. Punch JD, Shieck VL, Campbell DA, Bromberg JS, Turcotte JG, Merion RM. Corticosteroid withdrawal after liver transplantation. Surgery 1995: 118: 783.
4. Stegall MD, Wachs ME, Everson G et al. Prednisone withdrawal 14 days after liver transplantation with mycophenolate. Transplantation 1997: 64: 1755.
5. De Carlis L, Belli LS, Rondinara GF et al. Early steroid withdrawal in liver transplant patients: final report of a prospective randomized trial. Transplant Proc 1997: 29: 539.
6. Padbury RT, Gunson BK, Dousset B et al. Steroid withdrawal from long-term immunosuppression in liver allograft recipients. Transplantation 1993: 55: 789.
7. Qian S, Lu L, Fu F et al. Apoptosis within spontaneously accepted mouse liver allografts. Evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol 1997: 158: 4654.
8. Tisone G, Angelico M, Palmieri G et al. A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation. Transplantation 1999: 67: 1308.
9. Rolles K, Davidson BR, Burroughs AK. A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin. Transplantation 1999: 68: 1195.
10. Ringe B, Braun F, Schütz E et al. A novel management strategy of steroid-free inummosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil. Transplantation 2001: 71: 508.
11. Lucey MR. Changing perspectives on the role of corticosteroids after liver transplantation. Liver Transpl Surg 1999: 5: S58.
12. Reding R. Steroid withdrawal in liver transplantation. Transplantation 2000: 70: 405.
13. Pirenne J, Koshiba T. Present status and future prospects in liver transplantation. Int Surg 1999: 84: 297.
14. Maes B, Van Walleghem J, Kuypers D, Ghoos Y, Rutgeerts P, Van Renterghem Y. Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine. Transplantation 1999: 68: 1482.
15. Pirenne J, Aerts R, Koshiba T et al. Standard cyclosporine A-based versus completely steroid-free FK506-based immunosuppression after liver transplantation. Transplant Proc 2001: 33: 1505.
16. European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994: 344: 423.
17. The US Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994: 331: 1110.
18. Mirza D, Gunson B, Soonawalla ZF. Reduced acute rejection after liver transplantation with Neoral based triple immunosuppression. Lancet 1997: 349: 701.
19. Koshiba T, Van Damme B, Ji P et al. Addition of steroids blocks the tolerogenic potential of donor-specific blood transfusion (DSBT). Transplant Proc 2001: 33: 375.
20. Hudnall SD, Rady PL, Tyring SK, Fish JC. Hydrocortisone activation of human herpesvirus 8 viral DNA replication and gene expression in vitro. Transplantation 1999: 67: 648.
21. Kato T, Neff G, Montalbano M et al. Steroid-free induction with tacrolimus and daclizumab in liver transplant recipients with hepatitis C - a preliminary report of a prospective randomized trial. Am J Transplantation 2001: 1 (S1): 179.
22. Sileri P, Schena S, Mihalov M et al. Corticosteroids enhance hepatic injury following ischemia/reperfusion. Am J Transplantation 2001: 1 (S1): 347.
23. University of Pennsylvania. Dexamethasone inhibits hepatocellular recovery following ischemia reperfusion injury in liver transplantation. Proceedings of the American Association for the Study of Liver Diseases. Hepatology 1999: 30: 222A.
24. Pirenne J, Van Gelder F, Koshiba T et al. Influence of intraoperative steroids on ischemia/reperfusion injury (IRI) after liver transplantation (LTx). Am J Transplantation 2001: 1 (S1): 316.